Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole J Henry Dunand

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 22, 2015
Restricted, canonical, stereotyped and convergent immunoglobulin responsesCarole J Henry Dunand, Patrick C Wilson
Frontiers in Immunology|May 9, 2012
Exploiting human memory B cell heterogeneity for improved vaccine efficacyNoel T Pauli, Carole J Henry Dunand, Patrick C Wilson
Current Opinion in Immunology|June 9, 2016
Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?Karlynn E Neu, Carole J Henry Dunand, Patrick C Wilson
Nature Communications|June 10, 2014
Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cellsØyvind Steinsbø, Carole J Henry Dunand, Min Huang, et al.
International Journal of Cancer|December 3, 2014
CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopesCharline Vauchy, Clementine Gamonet, Christophe Ferrand, et al.
Diabetes|December 20, 2014
Loss of anergic B cells in prediabetic and new-onset type 1 diabetic patientsMia J Smith, Thomas A Packard, Shannon K O'Neill, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 14, 2014
Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritisAndrew J Kinloch, Anthony Chang, Kichul Ko, et al.
The Journal of Clinical Investigation|February 18, 2015
Preexisting human antibodies neutralize recently emerged H7N9 influenza strainsCarole J Henry Dunand, Paul E Leon, Kaval Kaur, et al.
Science Translational Medicine|December 4, 2015
Immune history profoundly affects broadly protective B cell responses to influenzaSarah F Andrews, Yunping Huang, Kaval Kaur, et al.
Plos One|May 8, 2015
High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After VaccinationKaval Kaur, Nai-Ying Zheng, Kenneth Smith, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 22, 2015
Restricted, canonical, stereotyped and convergent immunoglobulin responsesCarole J Henry Dunand, Patrick C Wilson
Frontiers in Immunology|May 9, 2012
Exploiting human memory B cell heterogeneity for improved vaccine efficacyNoel T Pauli, Carole J Henry Dunand, Patrick C Wilson
Current Opinion in Immunology|June 9, 2016
Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?Karlynn E Neu, Carole J Henry Dunand, Patrick C Wilson
Nature Communications|June 10, 2014
Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cellsØyvind Steinsbø, Carole J Henry Dunand, Min Huang, et al.
International Journal of Cancer|December 3, 2014
CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopesCharline Vauchy, Clementine Gamonet, Christophe Ferrand, et al.
Diabetes|December 20, 2014
Loss of anergic B cells in prediabetic and new-onset type 1 diabetic patientsMia J Smith, Thomas A Packard, Shannon K O'Neill, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 14, 2014
Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritisAndrew J Kinloch, Anthony Chang, Kichul Ko, et al.
The Journal of Clinical Investigation|February 18, 2015
Preexisting human antibodies neutralize recently emerged H7N9 influenza strainsCarole J Henry Dunand, Paul E Leon, Kaval Kaur, et al.
Science Translational Medicine|December 4, 2015
Immune history profoundly affects broadly protective B cell responses to influenzaSarah F Andrews, Yunping Huang, Kaval Kaur, et al.
Plos One|May 8, 2015
High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After VaccinationKaval Kaur, Nai-Ying Zheng, Kenneth Smith, et al.
Pageof 2